In the Renal Business Today interview NKC CEO Joyce Jackson reflects on NKC's past and future with home hemodialysis - remembering NKC's participation with the Aksys PHD's FDA 510(K) trial. NKC was also the launch site for the Aksys PHD after it received FDA approval - in the late summer of 2002 I was the first person to train and use the PHD.
Turning to the future:
We’re [NKC] really interested in DEKA’s announcement that they are working with Baxter. Dean Kamen’s firm is taking the Aksys technology and trying to turn it into the next version of home hemodialysis machine. We’re very interested in how that’s advancing.
Indeed we are.
I visited DEKA last September but I have no idea about the project's status. Baxter's development of a home hemodialysis machine would seem to be a good fit if Baxter/Fresenius takeover rumors are true. I hear FMC's Baby K is caught in a FDA rules tangle - the timing could be right to start fresh with a DEKA designed dialysis device.
Comments